FDA Adverse Event Injury Summary report: N

SINGLE USE ELECTROSURGICAL KNIFE

MDR report key: 24433581 · Received February 24, 2026

Report

Report Number
9614641-2026-00230
Event Type
Injury
Date Received
February 24, 2026
Date of Event
September 15, 2025
Report Date
March 16, 2026
Manufacturer
AOMORI OLYMPUS CO., LTD.
Product Code
KNS
PMA / PMN Number
K092309
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUPPLEMENTED TO PROVIDE ADDITIONAL INFORMATION BASED ON THE APPROVED FINAL INVESTIGATION. BASED ON THE RESULTS OF THE INVESTIGATION, AND SINCE THE DEVICE WAS NOT RETURNED FOR EVALUATION, THE DEFINITIVE ROOT CAUSE OF THE REPORTED ISSUE COULD NOT BE DETERMINED. OLYMPUS WILL CONTINUE TO MONITOR FIELD PERFORMANCE FOR THIS DEVICE.

Additional Manufacturer Narrative · 0

THE INVESTIGATION IS ONGOING. A SUPPLEMENTAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETED OR IF ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 0

NO ADDITIONAL INFORMATION WAS RECEIVED FROM THE CUSTOMER.

Description of Event or Problem · 0

OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED ¿FEASIBILITY AND SAFETY OF ENDOSCOPIC RESECTION FOR CARDIAL SUBMUCOSAL TUMORS MORE THAN 30 MM IN DIAMETER¿. BACKGROUND OF THE STUDY ENDOSCOPIC RESECTION HAS EMERGED AS A VIABLE OPTION FOR CARDIAL SUBMUCOSAL TUMORS (SMTS), BUT EXISTING EVIDENCE REMAINS LIMITED BY SMALL SAMPLE SIZES. THIS STUDY AIMED TO EVALUATE THE EFFICACY AND SAFETY OF ENDOSCOPIC RESECTION TECHNIQUES FOR CARDIAL SMTS MORE THAN 30 MM IN DIAMETER. METHODS BETWEEN (B)(6) 2012 AND (B)(6) 2024, 107 PATIENTS WITH CARDIAL SMTS LARGER THAN 30 MM WERE INCLUDED IN THIS STUDY. DATA ON PATIENT CHARACTERISTICS, CLINICAL OUTCOMES, AND FOLLOW-UP WERE RETROSPECTIVELY ANALYZED. RESULTS AMONG 107 PATIENTS, 42 PATIENTS UNDERWENT SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION (STER), 34 PATIENTS UNDERWENT ENDOSCOPIC FULL-THICKNESS RESECTION (EFTR), AND 31 PATIENTS RECEIVED ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD). THE MEAN LESION SIZE WAS 4.2 ± 1.9 CM. THE RATE OF EN BLOC RESECTION AND COMPLETE RESECTION WERE 94.3% AND 91.6%, RESPECTIVELY. POSTOPERATIVE ADVERSE EVENTS INCLUDED DELAYED BLEEDING (2 CASES), DELAYED PERFORATION (2 CASES), SUBCUTANEOUS EMPHYSEMA (2 CASES) AND PLEURAL EFFUSION (2 CASES). ONE CASE OF RECURRENCE WAS DETECTED DURING THE MEAN FOLLOW-UP PERIOD OF 37.4 ± 22.5 MONTHS. MULTIVARIATE ANALYSIS SHOWED IRREGULAR MORPHOLOGY (OR 2.076, 95% CI 0.513¿6.274, P = 0.039) AND INVASION INTO THE MUSCULARIS PROPRIA LAYER (OR 6.157, 95% CI1.160¿7.602, P = 0.031) WERE INDEPENDENT RISK FACTORS FOR INCOMPLETE RESECTION; LESION SIZE = 40 MM (OR 6.271, 95% CI 1.024¿7.856, P = 0.027), IRREGULAR MORPHOLOGY (OR 4.734, 95% CI 1.489¿6.052, P = 0.042), TRANS-CARDIA TUMOR (OR 5.526, 95% CI 1.160¿7.602, P = 0.043) AND INVASION INTO THE MUSCULARIS PROPRIA LAYER (OR 5.104, 95% CI 1.893¿7.965, P = 0.030) WERE INDEPENDENT RISK FACTORS FOR LONG OPERATIVE TIMES. CONCLUSION ENDOSCOPIC RESECTION IS AN EFFECTIVE AND SAFE TREATMENT FOR CARDIAL SMTS LARGER THAN 30 MM, PARTICULARLY WHEN PERFORMED BY EXPERIENCED ENDOSCOPISTS. LONG-TERM SURVEILLANCE REMAINS CRUCIAL FOR EARLY DETECTION OF RECURRENCE. TYPE OF ADVERSE EVENTS/NUMBER OF PATIENTS DELAYED BLEEDING IN 2 PATIENTS DELAYED PERFORATION IN 2 PATIENTS SUBCUTANEOUS EMPHYSEMA IN 2 PATIENTS. PLEURAL EFFUSION IN 2 PATIENTS. THIS REPORT IS 1 OF 2 FOR THE ADVERSE EVENTS INCLUDED IN THE ARTICLE. THERE WAS NO ALLEGATION OF DEVICE MALFUNCTION IDENTIFIED IN THE ARTICLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
486007 SINGLE USE ELECTROSURGICAL KNIFE SINGLE USE ELECTROSURGICAL KNIFE KNS AOMORI OLYMPUS CO., LTD. KD-611L NI

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention GIF-HQ290 GASTROINTESTINAL VIDEOSCOPE, SN -UNK| KD-620QR, ELECTROSURGICAL KNIFE, LOT-UNK